TY - JOUR
T1 - Prevention of cystic fibrosis
T2 - The beginning of the end?
AU - Ferkol, Thomas W.
N1 - Funding Information:
The author received support from the National Institutes of Health (grant nos. HL096458, HL116711, and HL125241) and the National Health and Medical Research Council (grant no. NHMRC1043768).
Publisher Copyright:
Copyright © 2019 The Authors, some rights reserved.
PY - 2019
Y1 - 2019
N2 - Prenatal and postnatal treatment with a CFTR modifier attenuates pathological changes in a ferret model of cystic fibrosis (Sun et al., this issue).
AB - Prenatal and postnatal treatment with a CFTR modifier attenuates pathological changes in a ferret model of cystic fibrosis (Sun et al., this issue).
UR - http://www.scopus.com/inward/record.url?scp=85063502581&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aax2361
DO - 10.1126/scitranslmed.aax2361
M3 - Article
C2 - 30918110
AN - SCOPUS:85063502581
SN - 1946-6234
VL - 11
JO - Science translational medicine
JF - Science translational medicine
IS - 485
M1 - eaax2361
ER -